The notion that polarity regulators can act as tumor suppressors in epithelial cells is now well accepted. The function of these proteins in lymphocytes is less well explored, and their possible function as suppressors of leukemia has had little attention so far. We review the literature on lymphocyte polarity and the growing recognition that polarity proteins have an important function in lymphocyte function. We then describe molecular relationships between the polarity network and signaling pathways that have been implicated in leukemogenesis, which suggest mechanisms by which the polarity network might impact on leukemogenesis. We particularly focus on the possibility that disruption of polarity might alter asymmetric cell division (ACD), and that this might be a leukemia-initiating event. We also explore the converse possibility that leukemic stem cells might be produced or maintained by ACD, and therefore that Dlg, Scribble and Lgl might be important regulators of this process.
Introduction
There is a growing recognition that polarity has an important function in the initiation and progression of solid tumors, based partly on observations that polarity is lost in malignant epithelial tumors, and that disruptions in polarity genes can lead to epithelial tumors in the fly and in mammals (Humbert et al., 2003; Bilder, 2004; Hezel and Bardeesy, 2008; Humbert et al., 2008; Januschke and Gonzalez, 2008) . A potential function for polarity in leukemia is less well explored, but recent observations have suggested that investigation into polarity will result in important advances in our understanding of leukemia, with potential therapeutic implications.
We will discuss current knowledge of the function and mechanisms of polarity in leukocytes, and how dysregulation of polarity might impact on leukemogenesis. Polarity has an important function in many of the likely cells of origin of leukemia and lymphoma, including hematopoietic stem cells (HSCs), myeloid cells and lymphocytes. Because polarity is best studied in mature T cells, we utilize that knowledge as a possible basis for broad considerations as to how polarity might impact on different stages of leukemia progression, including failure of differentiation, excessive proliferation, failure of compartmentalization, and failure of normal induction of apoptosis. We address a likely role for a relatively unexplored aspect of polarity in leukemic cells, asymmetric cell division (ACD). With regard to hematopoietic cells, the most convincing demonstration of ACD is in mature T cells and is therefore not obviously applicable to certain malignancies. However, the concepts of ACD can perhaps be applied to other malignancies, in particular myeloid leukemias. We discuss how the evidence that ACD can be controlled in non-adherent hematopoietic cells, combined with a role for ACD in stem cell self-renewal, might suggest a broad role in hematopoietic malignancies.
Polarity in lymphocytes
Although polarity has traditionally been studied in epithelial and developmental progenitor cells, polarity also regulates many physiologically important processes in leukocytes. These include processes such as migration, targeted secretion of cytolytic granules and cytokines, and compartmentalization of signaling to regulate processes such as T-cell activation by antigenpresenting cells (Zigmond et al., 1981; Russell, 2008) . Although there are broad similarities in the polarization of leukocytes and epithelial cells, there are also clear differences between the types of polarity adopted by leukocytes, and the cues that can initiate polarity (Krummel and Macara, 2006; Russell, 2008) . For instance, similar to adherent cells, migrating neutrophils and T cells have a leading edge rich in chemokine receptors. In contrast to adherent cells where the microtubule organizing center (MTOC) is generally at the leading edge, in migrating leukocytes the MTOC is at the rear (Affolter and Weijer, 2005; Russell, 2008) .
In addition to migratory polarity induced by chemokines, lymphocytes can polarize during activation by antigen-presenting cells to form an immunological synapse, which orchestrates the signaling response. Polarization during T-cell cytotoxicity or T-cell help also involves the establishment of an immunological synapse, to which the MTOC and secretory vesicles are recruited. This specifically targets cytotoxic granules and cytokines from the T cell to target cells (Stinchcombe and Griffiths, 2007) . Activated and migrating T cells have a single protrusion called a uropod, which contains adhesion receptors for interaction with other lymphocytes. Polarization is also induced by the ligation of surface receptors, for instance by pathogens. In this process, termed capping because the ligated surface proteins are recruited to a single site on the lymphocyte, the cap often aligns with the axis of polarity and occurs at the tip of the uropod.
The wide range of different forms of polarity that have been observed in lymphocytes perhaps reflects their dynamic behavior, and the fact that they are not constrained in solid tissue. Inputs that can dictate polarity include chemokines, antigen-presenting cells (dendritic cells, B cells, thymic epithelial cells), targets of cytotoxic T cells, vascular endothelium, extracellular matrix, homotypic adhesions (interactions with other lymphocytes) and interactions with pathogens ( Figure 1 ). Furthermore, leukocytes often reside in sites rich in competing cues for polarity such as the thymus (thymic epithelial cells or chemokines; Figure 2a ; Ladi et al., 2006; Yin et al., 2007) , the lymph nodes (dendritic cells or chemokines; Figure 2d ; Dustin, 2002) , and might well occur in the vascular tissue or at sites of infection (Figures 2b and c) . Thus, it is now apparent that the form of polarity adopted by the leukocyte is an important means by which multiple signals are integrated to determine a functional response (Bromley et al., 2000; Oliaro et al., 2006; Heit et al., 2008) .
Many recent studies have begun to elucidate the mechanisms by which polarity is established in T cells, and not surprisingly, there are some striking similarities between the molecular players in epithelial and T-cell polarity (Krummel and Macara, 2006) . Tumor suppressor members of the polarity network that regulate apical Many different cues can regulate leukocyte polarity. The leukocyte in the center can polarize (aligning the microtubule organizing center (MTOC) and nucleus depicted, as well as cytoplasmic and surface molecules) toward each of the cues illustrated. Polarity cues for leukemic cells might include anything that dictates polarization either of hematopoietic stem cells or of mature lymphocytes. This could include interaction with stromal cells (for instance, in the stem cell niche of the bone marrow), interaction with other cell types that can engage cell surface receptors to induce polarity (antigen presentation, triggers of the virological synapse, patching and capping of surface receptors), exposure to chemokines or extracellular matrix, or homotypic interactions (Russell, 2008) . Thus, the availability of the cues in a particular location and their ability to compete with each other to dictate polarity are likely to influence how polarity impacts on leukemogenesis.
basal polarity in epithelial cells are included in this list (Table 1) . Importantly, new evidence suggests that these proteins have diverse functions in regulating basic lymphocyte behavior. Knockdown of Scribble expression in a T-cell line abrogates migration ability and prevents the remodeling associated with antigen presentation (Ludford-Menting et al., 2005) . Discs large (Dlg, a member of the Scribble complex) is important for uropod formation, lipid raft and immunological synapse composition, and for the virological synapse induced by human T-cell leukemia virus (HTLV-1) infection (Blot et al., 2004; Xavier et al., 2004; LudfordMenting et al., 2005; Round et al., 2005) . There is also evidence for expression of both the Crumbs and the Par complexes in T cells (Humbert et al., 2006; Krummel and Macara, 2006) . A member of the Par complex, aPKC, controls lymphocyte homing, migration and scanning (Giagulli et al., 2004; Real et al., 2007) . Par3 controls polarity during chemokine stimulation by regulating the RhoGTPases, Rap1 and Rac1 (Gerard et al., 2007) . These observations indicate that the regulation of polarity is conserved across diverse cell types and species (Krummel and Macara, 2006; Russell, 2008) .
Polarity and the polarity network in solid tumors and leukemia
The best evidence that polarity is important in tumorigenesis is that loss of the Scribble complex genes (Scribble, Discs large (Dlg) and Lethal giant larvae (Lgl)) in Drosophila leads not only to loss of epithelial polarity but also to epithelial cancers (Humbert et al., 2003; Lee and Vasioukhin, 2008; Humbert et al., 2008) . In addition, aPKC, which antagonizes polarity mediated by the Scribble complex, can act as an oncogene (Lee and Vasioukhin, 2008; Aranda et al., 2008) , suggesting that the Par complex as a whole might Lgl was historically considered part of the Scribble complex based on genetic and functional evidence (Humbert et al., 2003; Kallay et al., 2006) . However, Lgl can also interact with members of the Par3 complex. The Par3 and Scribble complex exert antagonistic effects on each other in terms of localization, and this might occur at least in part because of a molecular antagonism between aPKC and Lgl (Humbert et al., 2006) . Because Dlg, Scribble and Lgl all act similarly in terms of tumor suppression, they are considered together in this review. Although the Drosophila Par3 complex proteins are not traditionally considered tumor suppressors, they can show tumor suppressor or oncogenic effects under certain circumstances (Humbert et al., 2008) .
balance the effects of the Scribble complex in tumor suppression. Validation that Scribble, Dlg and Lgl are also tumor suppressor genes in mammals has been difficult. This is in part due to early lethality in knockout mice, and also to the growing realization that these genes are likely to act in cooperation with others, and so will not be revealed by simple analysis of, for instance, mutations in cancers. Despite this complexity, a growing number of studies support the notion that mammalian polarity proteins also act as tumor suppressors (Aranda et al., 2008; Hezel and Bardeesy, 2008; Humbert et al., 2008; Thomas et al., 2008) . Given that the study of how polarity affects the function of lymphocytes is a relatively young field, it is not surprising that there has been little consideration of how diseases of the blood such as leukemia might be regulated by polarity proteins. However, the literature discussed below shows tantalizing anecdotal, morphological and functional data to suggest that polarity might have a function in leukemogenesis and prognosis.
How might polarity impact on leukemogenesis?
Lessons learnt from studying polarity in epithelial tumorigenesis have paved the way for us to begin to consider how polarity might affect leukemogenesis. The first notions relate to the concept that a loss of polarity leads to tumorigenesis, perhaps by altering cell-cell or cell-matrix interactions. This is supported by substantial evidence and continues to be an important concept in the field (Humbert et al., 2003; Lee and Vasioukhin, 2008) . A second stage of thinking relates to the concept that epithelial cancers undergo a transition to a more mesenchymal state that facilitates metastasis (termed epithelial to mesenchymal transition) (see MorenoBueno et al., 2008) , which might then involve a reversion back to an epithelial morphology in the new metastatic site (termed mesenchymal to epithelial transition) (Thiery and Sleeman, 2006) . This notion raises the possibility that cancer progression involves not so much loss of polarity, but changes from apicobasal polarity to migratory potential (Thiery and Sleeman, 2006) , for which Lgl, Scribble and Dlg might have important functions (Humbert et al., 2006; Etienne-Manneville, 2008) . Finally, as discussed in detail below, it is now thought that polarity in ACD might have very important functions in epithelial cancer progression. In considering possible roles for polarity in hematopoietic malignancies, we should consider not only that similar concepts might apply to the two cell types but also that the architecture of hematopoietic organs might have as important a function as the architecture of an epithelial tissue.
As described earlier, polarity in leukocytes can be triggered by many different cues, and can influence many processes. Thus, disruption of polarity could potentially regulate a number of different aspects of disease development. The origin of leukemia is likely to be important in considering how polarity might impact on cancer initiation or progression, because both the cell type and the site of leukemogenesis is likely to impact on the type of polarity involved. For instance, T-cell acute lymphoblastic leukemia (T-ALL) originates during thymocyte development, so presumably the initial oncogenic events occur in the thymus, where cells polarize both in response to chemokines and antigen presentation by thymic epithelial cells (Figure 2a ) (Ladi et al., 2006) . As discussed earlier, activated T cells and migrating T cells and neutrophils produce a single protrusion called a uropod, which contains adhesion receptors for interaction with other lymphocytes (Figures 2c and d) . Some leukemic cells were called 'hand-mirror cells' by pathologists because of evidence for a uropod in blood smears, but with no evident prognostic value, interest in hand-mirror cells has faded (Norberg et al., 1977; Schumacher et al., 1979) . Another example is adult T-cell leukemia/lymphoma (ATLL) which is caused by infection with the HTLV-1 retrovirus. Cells infected with HTLV-1 polarize to form a virological synapse that facilitates transfer of the virus to neighboring cells ( Figure 2b ). This process is orchestrated by the viral oncogene, Tax, which can bind directly with Dlg and Scribble, to influence proliferation (Igakura et al., 2003; Barnard et al., 2005; Javier, 2008) .
Interactions between the polarity network and signaling pathways involved in leukemogenesis
Many of the signaling pathways that have been implicated in leukemogenesis have the potential to functionally interact with the polarity proteins. Indeed, analysis in other cell types provides information on some intriguing molecular connections between polarity and the proteins that have been implicated as oncogenes or tumor suppressors in leukemia, and this information can now be exploited to produce some testable working models. Here, we consider a partial list of candidates for which there is some information.
Wnt
Signaling from the Wnt family of secreted lipoproteins regulates diverse cellular processes during development, and there is a growing recognition that Wnt has a function in leukemogenesis (Weerkamp et al., 2006; Staal et al., 2008) . The Wnt-regulated transcription factor, LEF1, is overexpressed in human leukemias, and constitutive activation of LEF1 in mice leads to B-cell lymphoblastic leukemia and acute myeloid leukemia (AML) (Petropoulos et al., 2008) . A number of observations suggest that Wnt is important in AML and chronic lymphocytic leukemia (Lu et al., 2004; Mikesch et al., 2007) , and abnormal methylation of Wnt pathway components is associated with poor prognosis in ALL patients (Roman-Gomez et al., 2007) . The central mediator of the Wnt canonical signaling pathway is the cytosolic protein b-catenin, which clearly has a function in leukemia. b-Catenin is stabilized by BCRAbl translocation in chronic myeloid leukemia (CML) (Coluccia et al., 2007) , and its expression in AML correlates with poor prognosis (Ysebaert et al., 2006) . Furthermore, the engineered stabilization of b-catenin in mouse thymocytes leads to malignant transformation (Guo et al., 2007) .
Although a relationship between Wnt and lymphocyte polarity is not yet established, the Wnt pathway regulates polarity in many other cellular systems, for example in Xenopus convergent extension (Tanegashima et al., 2008) and migrating mammalian fibroblasts (Schlessinger et al., 2007) . Wnt is classically considered the primary regulator of planar cell polarity, and there are many interactions between the Wnt pathway and the polarity network that support a functional relationship between Wnt signaling and cell polarity of adherent cells. These include the findings that the polarity network regulates adenomatous polyposis coli localization (Etienne-Manneville and Hall, 2003; EtienneManneville et al., 2005) , and that Dlg can interact with adenomatous polyposis coli to negatively regulate b-catenin signaling (Ishidate et al., 2000) . Polarity proteins also interact with the non-canonical, planar cell polarity Wnt pathways, as Lgl is regulated by the essential Wnt pathway component, Dishevelled (Dollar et al., 2005) and Scribble and Dlg interact with Vangl2 or Strabismus Montcouquiol et al., 2003) . Interestingly, the Wnt pathway also has an important function in the polarity switch that occurs during epithelial to mesenchymal transition in epithelial cancer (Huber et al., 2005) , and expression of b-catenin and Scribble showed tight correlation in colorectal neoplasia (Kamei et al., 2007) . Taken together, these observations suggest that the polarity network might also alter Wnt signaling in leukemia development or progression.
PTEN and phosphatidylinositol signaling
Phosphatase and tensin homolog (PTEN) is a phosphatase capable of regulating both proliferation and survival by opposing the effects of phosphotidylinositol-3-OH kinase (PI(3)K) activation. Thus, unsurprisingly, PTEN has been found to have a strong tumor suppressor function in solid tumors and in leukemia, and other members of this pathway also have a function in tumorigenesis (Cully et al., 2006; Steelman et al., 2008) . Decreased phosphorylation of PTEN (which is commonly associated with a reduction in PTEN signaling) has been found in approximately 75% of human AML patient samples. However, it is unlikely that this is a direct effect of PTEN modification as specific inactivating mutations have not been found frequently in these human AML samples (Dahia et al., 1999; Aggerholm et al., 2000) . Downregulation of PTEN induces ATLL-type multilobulated nuclear formation and is also associated with the cellular proliferation of malignant T-cell leukemias and lymphomas (Fukuda et al., 2005) .
PTEN regulates polarity of a number of cell types, and directly interacts with Par3 (Li et al., 2003; von Stein et al., 2005; Wu et al., 2007a) . Spatial separation of the PI(3)K products PtdIns(4,5)P2 and PtdIns(3,4,5)P3 is crucial for apical-basal cell polarity, where apical targeting of PTEN regulates the accumulation of the PI(3)K product PtdIns(4,5)P2, which in turn localizes Cdc42 and aPKC to dictate cell polarity (Comer and Parent, 2007; Martin-Belmonte et al., 2007) . A role for PTEN and the PI(3)K pathway is well established in neutrophils for recruitment to infection sites and prioritizing attention from chemokines to bacterial products (Figure 2c ) (Iijima et al., 2002; Van Keymeulen et al., 2006; Nishio et al., 2007; Heit et al., 2008) . Alterations in leukocyte polarity could therefore provide an alternative means of disrupting PTEN function to contribute to leukemogenesis. Notch Notch signaling regulates a wide variety of cellular processes, including stem cell maintenance and cell-fate decisions through the modification of differentiation, proliferation and apoptosis (Ehebauer et al., 2006) , and this is particularly well studied in the hematopoietic system (Rothenberg et al., 2008) . Notch signaling has a key function in the development of leukemia, particularly in T-ALL (Grabher et al., 2006) . Constitutive expression of an active signaling cleavage product of Notch under the TCRb promoter/enhancer is found in human T-ALL patients with a rare (7;9) (q34;q34.3) translocation (Ellisen et al., 1991) . More convincingly, mutations in the PEST domain of Notch, which lead to increased Notch signaling, are found in over 50% of all pediatric T-ALL cases (Weng et al., 2004) . These findings are also supported by a variety of animal models with deregulated Notch signaling that develop leukemia (Grabher et al., 2006) . The Notch signaling pathway is not classically considered to regulate polarity, however, Notch-1 signaling can negatively regulate the expression of PTEN (Palomero et al., 2007) and thus Notch-1 signaling might also have an important function in migration responses to chemokine signals. Additionally, signaling through the Notch pathway can be asymmetrically distributed by localization either of one of its ligands, or of the regulator of Notch, Numb (see Notch and ACD below). polarization of mature T cells in response to antigen presentation is accompanied by polarization of Numb , so loss of polarity might represent an additional means of deregulating Notch signaling in thymocytes to trigger T-ALL. Further support for a possible involvement of polarity in Notch-mediated tumorigenesis comes from a new mouse model of T-ALL, in which the constitutive activation of the T-cell polarity regulator, Rap1, leads to Notch activation and T-cell leukemia (Wang et al., 2008) .
ACD in leukocytes
One aspect of cell polarity that can have profound consequences during development is ACD (see review by Januschke and Gonzalez, 2008) . ACD involves the induction and maintenance of polarity during cell division, resulting in the production of two daughter cells with different molecular composition (reviewed by Betschinger and Knoblich, 2004; Morrison and Kimble, 2006) . The asymmetrically localized proteins often include determinants of cell fate, so ACD can orchestrate the differentiation of progeny in a highly regulated manner (Figure 3) . ACD regulates development from the first division of the fertilized zygote in many organisms, and also has a function in diverse developmental processes, including neuroblast differentiation and skin development. Depending on the cell type and physiological context, polarity during ACD can be triggered by extrinsic cues such as neighboring cells or a molecular marker of the site of fertilization.
ACD can also regulate proliferation potential, and an important function of ACD is the maintenance of selfrenewal capacity in stem cells. For instance, division of Drosophila neuroblasts involves the production of one daughter that can proliferate to form the differentiated neurons (the ganglion mother cell), and a second daughter that is a replica of the parent neuroblast (see Januschke and Gonzalez, 2008) . Similarly, Drosophila germline stem cells rely on ACD for determination of self-renewal and differentiation potential. The Drosophila germline stem cell divides to generate one daughter that remains tightly associated with the niche and retains stem cell-like properties, and another that initiates a differentiation program (Yamashita et al., 2003; Xie and Li, 2007) . The orientation of these divisions controls the molecular identity of daughter cells and their access to extrinsic signals that regulate stem cell identity. This appears to be a general pattern in ACD, one daughter follows a programmed pattern of proliferation and differentiation, and the self-renewing daughter inherits a propensity for quiescence along with the capacity for longevity. Appropriately therefore, ACD seems to have a function in almost every well-studied system involving stem cells or stem cell-like components (Morrison and Kimble, 2006) .
There is considerable interest in determining whether the self-renewal and differentiation of HSCs might also involve ACD. The comparatively slow progress in our understanding of this process reflects the difficulties in studying ACD in a motile cell without readily apparent tissue organization. The importance of the niche in the maintenance of HSCs has been the subject of much research in recent years, and most likely provides good clues as to where ACD of HSC might occur and how polarity during ACD might be regulated (Kiel and Morrison, 2008) . For instance, HSCs are often seen in close proximity with osteoblasts in the bone marrow, or endothelial cells from adjacent blood vessels in the bone marrow or sinusoids in extramedullary sites, and these might directly (through cell-cell interaction) or indirectly (through chemokine gradients) regulate polarity and ACD (Figure 4b ).
Some studies, operating on the assumption that ACD in HSC might be regulated by intrinsic polarity that could be mimicked in vitro, looked for asymmetry in the daughters of in vitro cultured HSCs (Takano et al., 2004; Giebel et al., 2006; Beckmann et al., 2007) . Identification of asymmetry under these conditions provided encouraging suggestions that ACD can occur in HSC, but the possibility that this asymmetry might occur through random differences in protein segregation could not be ruled out. Wu et al. (2007b) recently provided two important advances to these studies. First, by showing that asymmetry could be influenced by culture with different stromal cells, they provided the first evidence that ACD of HSC could be determined by extrinsic events. Second, using a green fluorescent protein-based reporter for Notch signaling, they demonstrated that ACD in HSC created signaling differences that were compatible with self-renewal of one daughter cell.
Although the concept that ACD might also regulate diversity and fate determination of more differentiated lymphocytes was raised decades ago (Sainte-Marie and Leblond, 1965; Metcalf and Wiadrowski, 1966) , it has come to prominence only recently with a study by Steve Reiner and colleagues . In this study, CD8 þ T cells were extracted from mice at the time of first division following Listeria infection, and mitotic lymphocytes inspected by microscopy to find clear evidence of asymmetry. Importantly, both Numb and the polarity regulators Scribble and aPKC were polarized in the dividing cells, indicating that the previously defined mechanisms of ACD were most likely conserved in lymphocytes. The asymmetric localization of surface molecules in the mitotic cells correlated with their bipolar distribution in the daughters. The daughters were sorted and subjected to functional analysis, which indicated that the putative distal daughter, but not the putative proximal daughter, was capable of generating a memory response. These exciting data not only demonstrate that ACD can occur in mature lymphocytes but also strongly suggest that ACD of lymphocytes regulates cell lineage determination (Figure 4d ) .
These experiments pave the way for future studies to determine whether ACD also occurs in other lymphocytes, and in T cells that are polarized under different circumstances (for instance, during responses to chemokines; Figure 4a interaction with other cells such as thymic epithelial cells, or homotypic adhesion; Figure 4c ). Indeed, the lineage developmental program for many hematopoietic cells involves waves of proliferation that include at least partial self-renewal (for instance, during thymocyte development, or expansion of myeloid and lympoid precursors). In each case, ACD might have a function in regulating the balance between expansion of differentiating cells, and maintenance of a precursor population.
How might ACD impact on leukemia?
Not surprisingly, key constituents in the regulation of ACD are the polarity regulators, including those designated as tumor suppressors (Gonzalez, 2007; Coumailleau and Gonzalez-Gaitan, 2008; Knoblich, 2008; Januschke and Gonzalez, 2008) . The Par3 complex has been implicated in ACD in a number of cell systems, originally with a role in the fertilized Caenorhabditis elegans oocyte (Kemphues et al., 1988; Aranda et al., 2008) . In Drosophila neuroblasts, Par3 (bazooka) cooperates with Par6 and aPKC to mediate the localization of cell-fate determinants to the opposite pole of the cell (Knoblich, 2008 Lee et al., 2006b; Knoblich, 2008) . Dlg coordinates orientation of the mitotic spindle with polarization of cell-fate determinants (Siegrist and Doe, 2005) , and is involved with Lgl in neuroblast asymmetry during ACD (Ohshiro et al., 2000) . These observations have led to the concept that the tumor suppressing activities of Scribble, Dlg and Lgl might, at least in part, involve their role in ACD (Gonzalez, 2007; Coumailleau and Gonzalez-Gaitan, 2008) .
The notion that ACD allows for the segregation of proliferative and self-renewal capacity into different daughters is important for current concepts of oncogenesis ( Figure 5 ). There is a growing thought that cancer might arise from stem cells in some instances (Bonnet and Dick, 1997; Cobaleda et al., 2000; Reya et al., 2001; Castor et al., 2005; Buzzeo et al., 2007) . Cancers might arise following the aberrant distribution of cell-fate determinants during the asymmetric division of a stem cell. Instead of generating one daughter that can selfrenew and one that proliferates rapidly but has a limited lifespan (Figure 5a ), this might generate a cell that has both self-renewal properties and the capacity to proliferate rapidly (Figure 5b ). Studies in Drosophila have provided strong proof for this hypothesis, and there is now a growing body of evidence in solid malignancies to suggest that disruptions in ACD can lead to hyperproliferation and cancer (Gonzalez, 2007; Coumailleau and Gonzalez-Gaitan, 2008) . One such example relates to the phenotype of mice in which the Scribble complex protein, Lgl, was deleted (Klezovitch et al., 2004) . Loss of Lgl disrupts ACD of neuronal precursors, which results in the expression of Numb in Figure 5 Many shades of gray in how asymmetric cell division (ACD) might lead to leukemia. (a) The classic picture of ACD relates to the idea that two daughter cells differentially adopt the properties of self-renewal (with quiescence, white cells) or some degree of differentiation (combined with rapid proliferation and a finite number of divisions, black cells). (b) Prevention of ACD might, in certain circumstances, lead to coinheritance of both self-renewal and proliferative capacity (gray), perhaps creating a population of cells that have increased propensity to become leukemic. (c) Alternatively, cancer might arise when ACD is slightly altered, for instance to subtly change either the proliferation rate of the 'self-renewing cells (that is, white cells become light gray) (i), or in the proliferative potential of the 'non-self-renewing cells' (that is, black cells become dark gray) (ii). Note that the pale gray cell in (i) not only has the potential to initiate a tumor but by its self-renewing properties would also have the capacity to act as a cancer stem cell.
each daughter, and the consequent overproliferation of the self-renewing cells, reminiscent of the proliferative disorder primitive neuroectodermal tumors) (Klezovitch et al., 2004) . The concept that cancers can arise from stem cells is particularly well supported for leukemia, and would therefore involve the subversion of HSC. Only slight enhancements of self-renewal potential in the proliferating population (Figure 5ci ), or conversely, of proliferative capacity in the differentiated population ( Figure  5cii) , could lead to lymphoproliferation that has the potential to predispose to the secondary transforming mutations commonly found in models of leukemia. With this model of ACD in mind, we can draw parallels with different stages of leukemogenesis. Accumulation of differentiated cells and ongoing division of stem cells as shown in Figure 5ci is similar to chronic phase in CML, and to the survival and proliferation of myeloblasts in AML, whereas Figure 5cii may reflect the CML blast crisis, and myeloproliferative diseases that precede acute leukemia (Nimer, 2008) . This process might not just apply to HSC, but hyperproliferation at any stage of hematopoietic development could predispose to leukemia, and could perhaps also arise by disruptions in ACD.
Indeed, recent studies showed that the conditional deletion of Dlg1 can negatively regulate proliferation of T cells under some circumstances (Stephenson et al., 2007) . Many of the proteins implicated in leukemia might therefore exert at least some of their effects by deregulating ACD, or by having altered function if they are not distributed appropriately during ACD of HSC. In support of this notion, expression of the NUP98-HOXA9 fusion protein associated with AML and CML altered the pattern of asymmetric versus symmetric divisions in HSC cultured with stromal cells (Wu et al., 2007b) . Here, we will discuss how ACD might impact on the three leukemogenic pathways described above.
Notch in ACD
Exposure to Notch ligands prevents differentiation of HSCs and causes them to maintain a stem cell-like character (Jones et al., 1998; Varnum-Finney et al., 1998) . Furthermore, components of the Notch signaling pathway are consistently asymmetric in the daughters of an ACD, and this is key for determining their differential cell fate (Knoblich, 2008) . In Drosophila, differential Notch activation in the daughters of an asymmetric division of a homogenous neuronal precursor population regulates the development of two distinct cell lineages (Lee et al., 2006a; Bowman et al., 2008) . Given the important role of Notch in regulating self-renewal potential, and differentiation, it is not hard to imagine that control of Notch signaling by ACD is an essential component of tumor suppression. Negative regulation of Notch signaling by the asymmetrically distributed protein Numb can influence apoptosis and differentiation during sensory organ development (Orgogozo et al., 2002) . Furthermore, the neuroblasts of a Drosophila mutant that expresses functional but unpolarized Numb displays an identical phenotype to those in Drosophila lacking Numb expression, providing even stronger evidence that the asymmetry of Numb dictates differential fate of the daughters (Bhalerao et al., 2005) . As described above, the observation that loss of Lgl gives rise to a primitive neuroectodermal tumor-like disorder due to mislocalization of Numb in ACD (Klezovitch et al., 2004) supports this notion. The recent observations by Tanishtha Reya and colleagues that Numb can be asymmetric in dividing HSC, and that this correlates with differential Notch activity in the daughter cell, provide for the exciting possibility that disruptions in ACD of HSC might predispose to leukemia by affecting Notch signaling (Wu et al., 2007b; Congdon and Reya, 2008) . The role of Dlg, Scribble and Lgl in the regulation of Numb localization during ACD (Knoblich, 2008) further suggests that alterations in their function might lead to leukemia by disrupting ACD and therefore self-renewal of HSC.
Wnt in ACD
Besides the role for Wnt in regulating polarity of a nondividing cell, the Wnt signaling pathway might also influence leukemia through ACD. A role for the Wnt pathway in ACD is highly conserved, and has been observed in C. elegans, sea anemone and zebrafish (Wikramanayake et al., 2003; Gong et al., 2004; Mizumoto and Sawa, 2007a, b; Hardin and King, 2008) . There is also growing evidence that Wnt signaling has an important function in self-renewal of hematopoietic progenitors and stem cells. The ligands for the Wnt pathway (Wnt proteins) are produced not only by HSC but also by other constituents of the HSC microenvironment (Rattis et al., 2004) . In vitro addition of Wnt, in addition to stem cell factor, inhibits differentiation and promotes growth of HSC.
These observations together suggest the possibility that Wnt signaling might regulate ACD to affect selfrenewal of HSC, and therefore that the Wnt signaling defects associated with leukemia might involve disruptions in ACD. Enforced expression of Wnt in granulocyte macrophage progenitors has been demonstrated to give them 'stem cell-like' self-renewal potential, and Wnt signaling is found to be upregulated in these progenitors in CML patients. Disruption of b-catenin in BCR-Abl animal models of leukemia reduces the ability of HSC to self-renew both in vivo and in vitro, significantly delays the development of disease and shifts the disease from a CML phenotype to an ALL phenotype (Zhao et al., 2007) .
PTEN in ACD
A role for PTEN in ACD has not been exhaustively studied, but is suggested by observations that PtdIns(3,4,5)P3 regulates spindle orientation in the HeLa cell line (Toyoshima et al., 2007) . PtdIns (3, 4, 5) P3 is maintained at both poles of a T cell on activation (Costello et al., 2002) , and can stabilize leukocyte polarity (Wang et al., 2002) , suggesting that it would have the capacity to regulate ACD in leukocytes.
Recently, animal studies have shed light on the function of PTEN in the maintenance of normal HSC function. In HSC, PTEN promotes quiescence and prevents entry into the cell cycle. Thus, HSC from mice lacking PTEN initially multiply rapidly; however, they are depleted within weeks, and display diminished self-renewal capacity in serial transplantation assays (Yilmaz et al., 2006; Zhang et al., 2006) . Furthermore, these mice develop a brief myeloproliferative disorder followed by acute leukemia (Yilmaz et al., 2006; Zhang et al., 2006) . As a result of PTEN inactivation, a population of cKit mid , CD3þ ve cells accumulate that are highly enriched for leukemia-initiating cells, develop further oncogenic mutations and are capable of disease transplantation to irradiated recipients (Guo et al., 2008) . These leukemia-initiating cells were found to migrate out of the bone marrow, colonize peripheral lymphoid organs and initiate the development of leukemic-like disease. LICs, which were capable of transferring disease, were also found in these peripheral organs (Guo et al., 2008) . Observations made using this animal model make two important points. First, they support the possibility that deregulation of ACD, by affecting the balance between self-renewal and proliferation, can lead to a population of cells with increased leukemic potential. Second, they also provide some support for the notion that polarity cues outside the bone marrow can also allow for self-renewal, perhaps by coordinating ACD. Thus, either PTEN might regulate ACD, or ACD might impact on PTEN function, and disruptions in this process might lead to leukemogenesis.
Leukemic stem cells
Just as a disruption in ACD can be considered an initiating event in the conversion of a stem cell to a cancer cell, the other side of the coin might be an adoption of ACD to enable the maintenance of cancer stem cells. The notion of a cancer stem cell is currently hotly debated, and the term means different things to different people. For the purposes of this review, we define a cancer stem cell as a cell within the heterogeneous population of cancer cells that is relatively quiescent, but has self-renewal properties that give it a capacity to regenerate the tumor bulk. This entity might, or might not be related to the putative 'cancer-initiating cell' described above that is proposed to arise from stem cells. Cancer stem cells, or leukemic stem cells, are of interest to oncologists because these might be the cells that can resist therapeutic regimens as a result of their quiescence. Cancer stem cells have been discussed for decades and there is considerable controversy related to this subject. However, confidence is growing that they have an important function in a number of malignancies, particularly in leukemia (Li and Neaves, 2006; Savona and Talpaz, 2008) .
As with normal stem cells, by definition a cell that can both self-renew and reconstitute the cancer bulk must be able to produce two daughters with different fates. The precedents described above indicate that this process might well be orchestrated by ACD. Furthermore, the idea that ACD can facilitate self-renewal by packaging of key determinants leads to the extreme (almost heretical) notion that perhaps any cell can generate daughters with different capacities for self-renewal and proliferation. Therefore, a cancer stem cell might arise from a more differentiated cancer cell, and might not necessarily be directly derived from the cancer-initiating cell (Figure 6a ). Thus, a major determinant of whether the daughters will adopt appropriate homeostasis or uncontrolled proliferation and cancer might, in addition to the identity of the parent cell, involve the ability of that parent cell to undergo ACD, and to asymmetrically package the molecular determinants of proliferation and self-renewal. That ACD might provide the capacity to regenerate self-renewal capacity from a more differentiated cell is compatible with the increasing identification of subsets of 'non-stem cells' that under certain conditions can be induced to adopt stem cell-like properties, and with the growing notion of plasticity among stem cell and more differentiated progenitors (Okita et al., 2007; Wernig et al., 2007) . Indeed, it has been proposed that the clones of myeloproliferative disorders might not only utilize the stem cell niche to orchestrate ACD but also might outcompete normal HSCs for that niche (Nimer, 2008) .
How might ACD be orchestrated in leukemic cells to generate or maintain a self-renewing population?
Again, understanding how and where ACD might be controlled in the cancer stem cell population is essential for elucidating the process. Leukemic stem cells might adopt mechanisms for enabling ACD that have nothing to do with their origin, for instance utilizing the polarity orchestrated by HTLV-1 in the case of ATLL (the virological synapse; Figure 2b ) (Mortreux et al., 2003; Yoshida et al., 2008) or perhaps other forms of homotypic adhesion (Figure 4c ). This would mean that ACD could occur wherever two leukemic cells interact, or even in the interaction between an infected and a noninfected cell. Alternatively, a leukemic stem cell might adopt the polarity cues of its precursor to mediate ACD. If the leukemic cell arises, for instance, from a thymocyte and the stem cells continue to reside in the thymus, then interactions with thymic epithelial cells might control ACD (Xue et al., 2008) . If a leukemic cell adopts the properties of a HSC, then it might utilize the HSC niche to enable ACD, and there is growing support for this concept. For instance, human AML cells transplanted into immunodeficient mice also engraft in the endosteal region of the bone marrow, and the putative leukemic stem cell population engraft better than the leukemic cells that do not express stem cell markers (Ishikawa et al., 2007) . This niche would provide an ideal environment both to orchestrate ACD of leukemic stem cells and to mediate distinct responses of the daughter cells (Figure 4b ).
Furthermore, structure and development of the niches themselves are also capable of being regulated, and the presence of abnormally localized immature precursors has been suggested to be a useful prognostic indicator in the diagnosis of myelodysplastic syndromes and chronic myelomonocytic leukemia (Verburgh et al., 2003; Ngo et al., 2008) . Therefore, we must also consider the possibility that manipulation and alterations of the niche itself, and not resident stem cells, might be a means to deregulate self-renewal and differentiation (Sneddon and Werb, 2007) . The next step is to demonstrate ACD in such an environment, and to begin exploring how disruption of ACD in the niche might impact on leukemic stem cell maintenance.
With regard to the concept of leukemic stem cells, one could then imagine a scenario in which the control of polarity and ACD in leukemic cells might regulate a capacity to flip between proliferative and self-renewal potential from one generation to another (Figure 6b ). Depending on the requirements for triggering ACD in a leukemia cell, it is possible that the occasional cell might make its way to, for instance, the endosteal niche of the bone marrow, or a particular region of the lymph node. If this environment is conducive to ACD, the cell could then generate a rapidly proliferating daughter as well as a self-renewing daughter (a leukemic stem cell). The leukemic stem cell might then stay in the niche and continue a slow but steady production of proliferating progeny and self-renewed daughters, but at any stage might leave the niche and consequently lose its stem celllike self-renewing properties. A recent study that provides some support for the notion of context-specific regulation of cancer stem cell self-renewal demonstrates that the direct injection of human ALL cells into the femur of immunodeficient mice allows for reestablishment of ALL irrespective of whether the injected cells are purified for stem cell-like immunophenotypes (le Viseur et al., 2008) . This study suggests that cancer cells can adopt the stem cell-like properties of selfrenewal and multipotency when provided with an appropriate niche, despite not expressing the classic stem cell markers.
Perhaps then, as well as looking for markers with which to prospectively identify and isolate leukemic stem cells, and determining how these behave when reintroduced into animals, we should also look at where and how ACD is facilitated, and whether this process corresponds to the production of self-renewing, relatively quiescent daughters. Fortunately, much of the work on cancer stem cells is now focused on identifying the niches that allow for self-renewal (Sneddon and Werb, 2007) , and this will enable assessment of how polarity and ACD might regulate the generation or maintenance of cancer stem cells.
How will we conclusively determine whether polarity and ACD have important functions in leukemia? The growing number of mice deficient in polarity proteins will enable assessment of the role of each in established murine models of leukemia. The rapidly improving ability to screen leukemias systematically for genomewide alterations in expression, SNPS and epigenetic modifications will allow for assessment of the involvement of each polarity gene in the context of other mutations. One important consideration is that as ACD by definition encompasses the classically considered role of proliferation, apoptosis, trafficking and so on, we will not easily dissect a function for ACD by standard molecular approaches. However, defining where and how ACD might occur will enable some more sophisticated approaches, particularly as means to disrupt ACD are rapidly being elucidated in other systems. As an example, overexpression of a portion of b-adrenergic receptor kinase can disrupt ACD (Sanada and Tsai, 2005) . Conditional expression of such a molecule at the time and place of ACD would enable the determination of whether the asymmetric distribution of molecules at the time of division is crucial for leukemic onset or progression. To perform the molecular dissections that enable clear models for the function of ACD in leukemia and leukemia stem cells, a number of questions must be answered first:
Can HSC, differentiated lymphocytes or leukemic cells be induced to undergo ACD given the appropriate cues and environment, and what are these cues? Can this lead to daughter cells with increased capacity for self-renewal, and are HSCs better able to selfrenew because they are more likely to undergo ACD? If so, is it their environment or intrinsic, stem cellspecific factors that influence their propensity for ACD?
What are the factors that dictate cell fate in the daughters of lymphocytes, HSCs or leukemic cells undergoing ACD? Can ACD of a differentiated cell create a daughter with self-renewal capacity? Are there similarities or cooperation between asymmetrically distributed proteins and the proteins implicated in leukemogenesis or prognosis? Do alterations in the distribution of proteins during ACD of lymphocytes or HSC predispose to leukemia? Does ACD allow for the generation and/or maintenance of a subset of leukemic cells with the capacity for quiescence and self-renewal?
Conclusion
Evidence is now very strong that polarity is likely to have an important function in leukemogenesis, and that Dlg, Scribble and Lgl might act as tumor suppressors in lymphocytes as well as in epithelial cells. Of particular interest is the possibility that ACD has key functions in leukemia. This could occur at two levels. First, ACD might be important in preventing leukemia, for instance by segregating self-renewal and proliferative potential into the two daughter cells of a HSC. Second, ACD might enable the generation and maintenance of leukemic stem cells.
